These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31471273)

  • 21. Follicular CD4 T Helper Cells As a Major HIV Reservoir Compartment: A Molecular Perspective.
    Aid M; Dupuy FP; Moysi E; Moir S; Haddad EK; Estes JD; Sekaly RP; Petrovas C; Ribeiro SP
    Front Immunol; 2018; 9():895. PubMed ID: 29967602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression.
    Bull ME; McKernan JL; Styrchak S; Kraft K; Hitti J; Cohn SE; Tapia K; Deng W; Holte S; Mullins JI; Coombs RW; Frenkel LM
    AIDS Res Hum Retroviruses; 2019 Jun; 35(6):557-566. PubMed ID: 30892052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4
    Obregon-Perko V; Bricker KM; Mensah G; Uddin F; Kumar MR; Fray EJ; Siliciano RF; Schoof N; Horner A; Mavigner M; Liang S; Vanderford T; Sass J; Chan C; Berendam SJ; Bar KJ; Shaw GM; Silvestri G; Fouda GG; Permar SR; Chahroudi A
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33087463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between intact HIV-1 proviruses in circulating CD4
    Lu CL; Pai JA; Nogueira L; Mendoza P; Gruell H; Oliveira TY; Barton J; Lorenzi JCC; Cohen YZ; Cohn LB; Klein F; Caskey M; Nussenzweig MC; Jankovic M
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11341-E11348. PubMed ID: 30420517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review: Influence of ART on HIV genetics.
    Simonetti FR; Kearney MF
    Curr Opin HIV AIDS; 2015 Jan; 10(1):49-54. PubMed ID: 25389802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques.
    Abreu CM; Veenhuis RT; Avalos CR; Graham S; Parrilla DR; Ferreira EA; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Mac Gabhann F; O'Connor SL; Gama L; Clements JE
    mBio; 2019 Aug; 10(4):. PubMed ID: 31431552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging PCR-Based Techniques to Study HIV-1 Reservoir Persistence.
    Lambrechts L; Cole B; Rutsaert S; Trypsteen W; Vandekerckhove L
    Viruses; 2020 Jan; 12(2):. PubMed ID: 32012811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-molecule techniques to quantify and genetically characterise persistent HIV.
    Wang XQ; Palmer S
    Retrovirology; 2018 Jan; 15(1):3. PubMed ID: 29316955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on-going viral transcription.
    Pannus P; Rutsaert S; De Wit S; Allard SD; Vanham G; Cole B; Nescoi C; Aerts J; De Spiegelaere W; Tsoumanis A; Couttenye MM; Herssens N; De Scheerder MA; Vandekerckhove L; Florence E
    J Int AIDS Soc; 2020 Feb; 23(2):e25453. PubMed ID: 32107887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption.
    Cole B; Lambrechts L; Boyer Z; Noppe Y; De Scheerder MA; Eden JS; Vrancken B; Schlub TE; McLaughlin S; Frenkel LM; Palmer S; Vandekerckhove L
    Cell Rep; 2022 Apr; 39(4):110739. PubMed ID: 35476994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV reservoir dynamics in the face of highly active antiretroviral therapy.
    Costiniuk CT; Jenabian MA
    AIDS Patient Care STDS; 2015 Feb; 29(2):55-68. PubMed ID: 25412339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound.
    López-Huertas MR; Gutiérrez C; Madrid-Elena N; Hernández-Novoa B; Olalla-Sierra J; Plana M; Delgado R; Rubio R; Muñoz-Fernández MÁ; Moreno S
    Sci Rep; 2020 Dec; 10(1):22286. PubMed ID: 33339855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy.
    Kearney MF; Spindler J; Shao W; Yu S; Anderson EM; O'Shea A; Rehm C; Poethke C; Kovacs N; Mellors JW; Coffin JM; Maldarelli F
    PLoS Pathog; 2014 Mar; 10(3):e1004010. PubMed ID: 24651464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combating the HIV reservoirs.
    van Marle G; Church DL; van der Meer F; Gill MJ
    Biotechnol Genet Eng Rev; 2018 Apr; 34(1):76-89. PubMed ID: 29781356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy.
    Lerner P; Guadalupe M; Donovan R; Hung J; Flamm J; Prindiville T; Sankaran-Walters S; Syvanen M; Wong JK; George MD; Dandekar S
    J Virol; 2011 May; 85(10):4772-82. PubMed ID: 21345945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Latency reversal plus natural killer cells diminish HIV reservoir in vivo.
    Kim JT; Zhang TH; Carmona C; Lee B; Seet CS; Kostelny M; Shah N; Chen H; Farrell K; Soliman MSA; Dimapasoc M; Sinani M; Blanco KYR; Bojorquez D; Jiang H; Shi Y; Du Y; Komarova NL; Wodarz D; Wender PA; Marsden MD; Sun R; Zack JA
    Nat Commun; 2022 Jan; 13(1):121. PubMed ID: 35013215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue.
    Morón-López S; Puertas MC; Gálvez C; Navarro J; Carrasco A; Esteve M; Manyé J; Crespo M; Salgado M; Martinez-Picado J
    PLoS One; 2017; 12(4):e0175899. PubMed ID: 28414780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.
    Henrich TJ; Hanhauser E; Marty FM; Sirignano MN; Keating S; Lee TH; Robles YP; Davis BT; Li JZ; Heisey A; Hill AL; Busch MP; Armand P; Soiffer RJ; Altfeld M; Kuritzkes DR
    Ann Intern Med; 2014 Sep; 161(5):319-27. PubMed ID: 25047577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
    Cummins NW; Rizza S; Litzow MR; Hua S; Lee GQ; Einkauf K; Chun TW; Rhame F; Baker JV; Busch MP; Chomont N; Dean PG; Fromentin R; Haase AT; Hampton D; Keating SM; Lada SM; Lee TH; Natesampillai S; Richman DD; Schacker TW; Wietgrefe S; Yu XG; Yao JD; Zeuli J; Lichterfeld M; Badley AD
    PLoS Med; 2017 Nov; 14(11):e1002461. PubMed ID: 29182633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.